1. What conditions has Thiamine been studied for?

• Thiamine deficiency disorders (TDDs) with multi-system involvement (metabolic, neurologic, cardiovascular, respiratory, gastrointestinal, musculoskeletal), including severe and rapidly progressive presentations.

• Wernicke encephalopathy (WE) and Korsakoff psychosis (KP) (Wernicke–Korsakoff syndrome, WKS) related to thiamine deficiency and/or impaired utilization (alcoholic and non-alcoholic etiologies; genetic susceptibilities discussed).

• Pediatric neurologic and psychiatric morbidity associated with deficiency (ranging from confusion/memory issues to encephalopathy/ataxia), and putative supplementation effects in autism spectrum disorder (ASD) and other neurologic conditions (review-level discussion).

• Heart failure (HF): thiamine deficiency described as a risk factor; supplementation tested in symptomatic HF in randomized controlled trials (RCTs) summarized in a meta-analysis.

• Type 2 diabetes and diabetic complications / glucose metabolism: benfotiamine (a higher-bioavailability thiamine precursor) discussed as improving complications in type 2 diabetes; thiamine deficiency in diabetes linked mechanistically to oxidative stress, inflammation, and endothelial dysfunction (review-level).

• Neurodegenerative disease models: benfotiamine reported to have beneficial effects in mouse models (preclinical evidence).

• Charcot–Marie–Tooth (CMT) neuropathy: pilot study of oral thiamine and single-case observations with sulbutiamine/benfotiamine.

• Population-level infant outcomes: infantile beriberi and infant mortality in high-risk regions; maternal/infant supplementation and fortification discussed.

• Microbiome-related “metabiotics/postbiotics”: thiamine described as a metabolite produced or induced by probiotics, with relevance to energy metabolism regulation (mechanistic review context).

• Bee pollen as a supplement source: bee pollen contains thiamine among other compounds; therapeutic claims are discussed but not established (composition variability noted).

2. Does it work in treating those conditions? Summarize the evidence.

• Thiamine deficiency disorders (including severe presentations): The studies emphasize that early therapeutic thiamine is currently the best approach when deficiency is suspected, because specific diagnostic tests are lacking and misdiagnosis is common. They report that even severe cases can show rapid clinical improvement within hours or days, though neurologic involvement may require higher doses and longer recovery. However, they also note that optimal dosing regimens for different TDD presentations remain uncertain.

• Wernicke–Korsakoff syndrome (WE/KP): The review describes WKS as underdiagnosed due to variable presentation and symptom overlap. It emphasizes that identification and individualized treatment of WE based on etiology is vital to prevent progression to KP, particularly in genetically predisposed individuals. The study supports thiamine’s therapeutic role conceptually/clinically, but does not provide trial effect sizes.

• Heart failure: A systematic review/meta-analysis of 6 RCTs (n=298) found thiamine supplementation produced no significant effect on multiple outcomes including LVEF (p=0.08), NT-proBNP (p=0.94), LVEDV (p=0.53), 6-minute walk test (p=0.59), mortality (p=0.61), hospitalization (p=0.53), and dyspnea (p=0.77). Heart rate was the only significant outcome (p=0.04). Overall, this study suggests limited evidence of clinical benefit in HF beyond heart rate.

• CMT neuropathy: A pilot study reported that daily oral thiamine (100 mg) increased hand grip strength in CMT patients. Single cases with sulbutiamine (200 mg) or benfotiamine (150 mg) showed effects on measured biochemical parameters within the range of thiamine. This is promising but limited by small size/pilot design and reliance on functional and biomarker changes rather than large clinical endpoints.

• Type 2 diabetes / complications: A review reports that benfotiamine (a thiamine precursor with higher bioavailability and tissue penetration) improves complications observed in type 2 diabetes and shows antioxidant/anti-inflammatory potential in activated immune and glial cells. As presented, this is largely review-based and not quantified in the study; strength depends on underlying study quality (not detailed here).

• Infantile beriberi / public health interventions: In regions where deficiency is prevalent, food fortification and maternal and/or infant thiamine supplementation have proven effective in raising thiamine status and reducing infantile beriberi incidence, but the study cautions that trial data are limited.

• ASD and other neurologic conditions: The pediatric-focused review mentions a putative beneficial effect of thiamine supplementation in ASD and other neurologic conditions, but the study does not provide clinical trial results; evidence level cannot be confirmed from the study alone.

3. What health benefits does it have?

• Core biochemical role in energy metabolism: Thiamine is an essential, water-soluble vitamin and a cofactor for multiple enzymes (noted as largely mitochondrial), supporting carbohydrate utilization and ATP production.

• Nervous system support (especially brain): The brain is described as highly vulnerable to deficiency due to reliance on mitochondrial ATP; deficiency is associated with a spectrum from mild neuropsychiatric symptoms (confusion, reduced memory, sleep disturbances) to severe encephalopathy and ataxia. Preventing/correcting deficiency is therefore a key neurologic benefit.

• Cardiovascular relevance in deficiency states: Deficiency is linked to cardiovascular manifestations (including congestive heart failure in severe deficiency). In established symptomatic HF, supplementation showed minimal benefit in RCT meta-analysis outcomes, but correcting deficiency remains clinically important.

• Potential antioxidant/anti-inflammatory effects (especially for benfotiamine): Benfotiamine is described as having antioxidant and anti-inflammatory potential in activated immune and glial cells, and as beneficial in type 2 diabetes complications and mouse neurodegenerative models (preclinical).

• Public health/infant outcomes in high-risk regions: Fortification and maternal/infant supplementation can raise thiamine status and reduce infantile beriberi incidence; the study also highlights concern that even subclinical childhood deficiency may have lifelong neurodevelopmental consequences.

• Possible functional benefit in CMT neuropathy: Pilot data suggest improved hand grip strength with thiamine administration, alongside measurable changes in thiamine status biomarkers and transketolase regulation.

4. Does it have any downsides or side effects?

The studies reviewed here focus primarily on deficiency consequences and potential benefits; they do not provide a detailed adverse-event profile for thiamine, benfotiamine, or sulbutiamine.

• Clinical downside: underdiagnosis and missed treatment is emphasized as a major risk—TDDs are frequently misdiagnosed due to broad, overlapping symptoms and lack of readily accessible biomarkers, potentially leading to fatal outcomes or permanent neurologic sequelae if untreated.

• Uncertainty about dosing regimens: One review explicitly notes that more research is needed to determine effective dosing regimens across different TDD presentations; this implies potential risk of under-treatment (and possibly inconsistent practice) rather than documented toxicity.

• Bee pollen caveats (as a “natural” source that includes thiamine): The bee pollen review highlights major species-specific variation in composition and states that while it can be recommended as a dietary supplement, extensive research is required before therapeutic use. This is not thiamine-specific toxicity, but it is a safety/standardization limitation relevant to supplement use.

• Thiamine antivitamins (not supplements): A review describes synthetic thiamine antagonists (e.g., amprolium, pyrithiamine, oxythiamine) that inhibit thiamine-dependent processes and are explored/used as drugs (e.g., coccidiosis treatment; investigated as cytostatics). These are not typical “downsides” of thiamine supplementation, but they underscore that blocking thiamine pathways can have potent biological effects.

Because adverse effects are not described in these studies, conclusions about side effects of supplemental thiamine/benfotiamine cannot be made from this evidence set alone.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

• Genetic susceptibility in WKS: The Wernicke–Korsakoff review states that genetic susceptibilities (alongside acquired causes such as alcohol-related and non-alcohol-related factors) are associated with thiamine deficiency or impaired utilization, and that preventing progression to KP may be particularly important in genetically predisposed individuals. The study does not specify genes/variants or genotype-guided dosing.

• CMT-specific biochemical response differences: In the CMT pilot study, average baseline thiamine status markers did not differ from controls, but transketolase regulation differed: ThDP activated transketolase in controls but not in CMT patients, and thiamine administration paradoxically decreased endogenous holo-transketolase in CMT (not seen in controls). The authors also report sex-specific differences in correlations among thiamine-status parameters. This suggests disease/genetic-background-related differences in thiamine biochemistry and response, but it does not identify specific variants.

• Overall: Across these studies, pharmacogenomic evidence is suggestive (genetic predisposition and differential enzyme regulation) but not yet actionable—no specific genetic variants, testing strategies, or genotype-based recommendations are provided.

Vitamin B1 and Mitochondrial Health

The article highlights the essential function of vitamin B1 (thiamin) in maintaining mitochondrial health through its role in the citric acid cycle. Vitamin B1 deficiency can lead to compromised mitochondrial function and potential health issues. The review also touches upon the importance of other B vitamins, such as B2, B3, B5, and B7, in various metabolic processes.

Importance of Vitamin B1

• Acts as a coenzyme in the citric acid cycle, which is critical for energy production.
• Deficiency can impair mitochondrial function and energy metabolism.

Additional B Vitamins and Health

Other B vitamins like B2, B3, B5, and B7 play significant roles in maintaining mitochondrial function and overall metabolic health. The article also notes the importance of B6, folate, and B12 in one-carbon metabolism, DNA/RNA synthesis, and potential implications for age-related diseases.

Implications for Health and Disease

Research suggests that B vitamins can alleviate symptoms of deficiency and protect against mitochondrial toxicity. Furthermore, they may serve as antioxidants to combat oxidative stress. However, the article also mentions that excessive intake of certain B vitamins, particularly B6 and B12, may increase the risk of lung cancer in men, especially smokers.

Conclusion

The review concludes that while B vitamins, including B1, are essential for metabolic and mitochondrial health, their supplementation requires careful consideration due to varying effects on health and disease risk.

References:

1. Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism
2. Folate, vitamin B12 and vitamin B6 and one carbon metabolism
3. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention
4. Long-Term, Supplemental, One-Carbon Metabolism-Related Vitamin B Use in Relation to Lung Cancer Risk in the Vitamins and Lifestyle (VITAL) Cohort
5. VITamins And Lifestyle cohort study: study design and characteristics of supplement users
6. Folate and colorectal cancer: an evidence-based critical review
7. The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects
8. One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling
9. Thiamine deficiency disorders: a clinical perspective.
   Taryn J Smith, Casey R Johnson, Roshine Koshy, Sonja Y Hess, Umar A Qureshi, Mimi Lhamu Mynak, Philip R Fischer (2021) - Annals of the New York Academy of Sciences
10. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs.
    Kyly C Whitfield, Megan W Bourassa, Bola Adamolekun, Gilles Bergeron, Lucien Bettendorff, Kenneth H Brown, Lorna Cox, Aviva Fattal-Valevski, Philip R Fischer, Elizabeth L Frank, Laurent Hiffler, Lwin Mar Hlaing, Maria Elena Jefferds, Hallie Kapner, Sengchanh Kounnavong, Maral P S Mousavi, Daniel E Roth, Maria-Nefeli Tsaloglou, Frank Wieringa, Gerald F Combs (2018) - Annals of the New York Academy of Sciences
11. Biological and therapeutic properties of bee pollen: a review.
    Bożena Denisow, Marta Denisow-Pietrzyk (2016) - Journal of the science of food and agriculture
12. Neurological, Psychiatric, and Biochemical Aspects of Thiamine Deficiency in Children and Adults.
    Shibani Dhir, Maya Tarasenko, Eleonora Napoli, Cecilia Giulivi (2019) - Frontiers in psychiatry
13. Mechanisms and Therapeutic Potential of Key Anti-inflammatory Metabiotics: Trans-Vaccenic Acid, Indole-3-Lactic Acid, Thiamine, and Butyric Acid.
    Muñoz-Olivos Cristina, Bautista-Rodriguez Elizabeth, Rivas-Arreola María Jose, Palacios-Gonzalez Berenice, Zacapa Diego, Cortez-Sanchez Jose Luis (2025) - Probiotics and antimicrobial proteins
14. Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis.
    Abin Chandrakumar, Aseem Bhardwaj, Geert W 't Jong (2018) - Journal of basic and clinical physiology and pharmacology
15. Thiamine and benfotiamine: Focus on their therapeutic potential.
    Iva Bozic, Irena Lavrnja (2023) - Heliyon
16. Does thiamine supplementation affect heart failure? A systematic review and meta-analysis of randomized control trials.
    Abdul Rehman Shah Syed, Abdul Ahad Syed, Abdullah Akram, Muhammad Shaheryar Azam, Muhammad Ali Muzammil, Deepak, Ayesha Irshad Ansari, Farea Eqbal, Muhammad Haris Farooq, Mahima Khatri, Satesh Kumar, Nomesh Kumar (2023) - Heart & lung : the journal of critical care
17. Thiamine and selected thiamine antivitamins - biological activity and methods of synthesis.
    Adam Tylicki, Zenon Łotowski, Magdalena Siemieniuk, Artur Ratkiewicz (2018) - Bioscience reports
18. Pharmacological Doses of Thiamine Benefit Patients with the Charcot-Marie-Tooth Neuropathy by Changing Thiamine Diphosphate Levels and Affecting Regulation of Thiamine-Dependent Enzymes.
    Artem V Artiukhov, Olga N Solovjeva, Natalia V Balashova, Olga P Sidorova, Anastasia V Graf, Victoria I Bunik (2024) - Biochemistry. Biokhimiia
19. Thiamine deficiency in diabetes mellitus and the impact of thiamine replacement on glucose metabolism and vascular disease.
    G L J Page, D Laight, M H Cummings (2011) - International journal of clinical practice
20. Thiamine functions as a key activator for modulating plant health and broad-spectrum tolerance in cotton.
    Weixi Li, Xinyue Mi, Xuanxiang Jin, Daiwei Zhang, Guozhong Zhu, Xiaoguang Shang, Dayong Zhang, Wangzhen Guo (2022) - The Plant journal : for cell and molecular biology
21. Thiamine deficiency and cardiovascular disorders.
    E S Eshak, A E Arafa (2018) - Nutrition, metabolism, and cardiovascular diseases : NMCD
22. Vitamin C and Thiamine for Sepsis and Septic Shock.
    Anna B Mitchell, Tenley E Ryan, Amanda R Gillion, Lindsey D Wells, Muthiah P Muthiah (2020) - The American journal of medicine
23. Thiamine Deficiency in Tropical Pediatrics: New Insights into a Neglected but Vital Metabolic Challenge.
    Laurent Hiffler, Benjamin Rakotoambinina, Nadia Lafferty, Daniel Martinez Garcia (2016) - Frontiers in nutrition
24. Thiamine: An indispensable regulator of paediatric neuro-cardiovascular health and diseases.
    Ysphaneendramallimoggala, Monalisa Biswas, Stanly Elstin Anburaj, Faiza Iqbal, Shrikiran A, Varashree Bolar Suryakanth, Leslie Edward S Lewis (2024) - European journal of pediatrics
25. Thiamine: a key nutrient for yeasts during wine alcoholic fermentation.
    Pwj Labuschagne, B Divol (2021) - Applied microbiology and biotechnology
26. Thiamine deficiency-related neuropathy: A reversible entity from an endemic area.
    Sobia Nisar, Irfan Yousuf Wani, Umair Altaf, Umar Muzaffer, Ozaifa Kareem, Masood Tanvir, Mohd Ashraf Ganie (2024) - European journal of neurology
27. Substrate transport and drug interaction of human thiamine transporters SLC19A2/A3.
    Peipei Li, Zhini Zhu, Yong Wang, Xuyuan Zhang, Chuanhui Yang, Yalan Zhu, Zixuan Zhou, Yulin Chao, Yonghui Long, Yina Gao, Songqing Liu, Liguo Zhang, Pu Gao, Qianhui Qu (2024) - Nature communications
28. Thiamine (vitamin B1) in septic shock: a targeted therapy.
    Ari Moskowitz, Michael W Donnino (2020) - Journal of thoracic disease

Upload Whole Genome Sequencing (WGS) raw DNA data today and take a deep dive into your genome!

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Or if you only have standard microarray data currently, upload raw DNA data to get started with your free DNA raw data analysis today!